Related by context. All words. (Click for frequent words.) 78 Nexavar sorafenib 74 Bayer Nexavar 73 Alimta pemetrexed 73 Tykerb lapatinib 73 sorafenib Nexavar 73 sunitinib Sutent 72 Gemzar gemcitabine 72 thalidomide Thalomid 72 Velcade bortezomib 71 AstraZeneca Iressa 71 Noxafil 71 GW# [003] 70 Bevacizumab Avastin 70 Azacitidine 70 Peginterferon alfa 2b 70 Romiplostim 70 Ixempra 70 Sutent sunitinib 70 etanercept Enbrel 70 irinotecan oxaliplatin 70 Mepact 70 Femara letrozole 70 Torisel 70 Pfizer Sutent 70 brivanib 70 Iressa gefitinib 70 Sprycel dasatinib 70 Taxotere chemotherapy 70 Irinotecan 69 Vidaza azacitidine 69 Nexavar tablets 69 Taxotere docetaxel 69 Aflibercept 69 Roche Herceptin 69 Merck KGaA Erbitux 69 Cancidas 69 Gleevec imatinib mesylate 69 cetuximab Erbitux 69 Temodar ® 69 TORISEL TM 69 Avastin bevacizumab 69 Arranon 69 Sutent sunitinib malate 69 Arzerra ofatumumab 69 Arimidex anastrozole 69 bevacizumab Avastin ® 69 Gleevec imatinib 69 Zarnestra 69 ® lenalidomide 68 R lenalidomide 68 Fluconazole 68 erlotinib Tarceva ® 68 adalimumab Humira 68 cetuximab Erbitux R 68 hormone refractory metastatic prostate 68 Temsirolimus 68 Liprotamase 68 lenalidomide Revlimid 68 Plaquenil 68 Revlimid lenalidomide 68 LSE ASM 68 PF # [002] 68 pregabalin Lyrica 68 Reminyl galantamine 68 Wyeth Torisel 68 Erbitux cetuximab 68 Taxol paclitaxel 68 AVASTIN 68 Fondaparinux 68 Initiates Enrollment 68 IV Busulfex 68 Hycamtin 68 Muraglitazar 68 malignant ascites 68 Receives Orphan Drug Designation 68 Patients Treated With 68 myelodysplastic myeloproliferative diseases 68 Sanofi Aventis Taxotere 68 oropharyngeal candidiasis OPC 68 Belatacept 68 Bayer Onyx 67 Initiates Clinical Trial 67 MAGE A3 ASCI 67 Romidepsin 67 Mirapexin 67 Orphan Designation 67 midstage clinical 67 Vandetanib 67 dasatinib Sprycel ® 67 Initiates Phase III 67 refractory chronic lymphocytic 67 capecitabine Xeloda 67 IgG1 monoclonal antibody 67 IL# PE#QQR 67 anastrozole Arimidex 67 lumiliximab 67 Pazopanib 67 docetaxel Injection Concentrate 67 mycophenolic acid 67 trastuzumab Herceptin ® 67 recurrent glioblastoma multiforme 67 gefitinib Iressa 67 docetaxel Taxotere ® 67 paclitaxel Taxol R 67 Vertex hepatitis C 67 Luveris 67 anthracycline taxane 67 Camptosar ® 67 OSI Tarceva 67 Lambert Eaton Myasthenic 67 Dementia Related Psychosis 67 docetaxel Taxotere 67 bevacizumab Avastin 67 trastuzumab Herceptin R 67 R sorafenib tablets 67 Pegintron 66 Multaq dronedarone 66 NICE Recommends 66 metastatic colorectal 66 5 fluorouracil leucovorin 66 BioSante Pharmaceuticals Announces 66 Campto 66 drug belatacept 66 Myelodysplastic Syndrome MDS 66 abatacept Orencia 66 drug Treanda 66 Abacavir 66 Zenapax 66 Aviptadil 66 Erlotinib 66 Votrient 66 Pulminiq 66 Severe Sepsis 66 Roche Xeloda 66 oxaliplatin Eloxatin 66 Removab 66 humanised monoclonal antibody 66 Roche MabThera 66 SUTENT ® 66 Exelon rivastigmine 66 receptor tyrosine kinase inhibitor 66 lexidronam injection 66 Psoriasis Drug 66 Meets Primary Endpoint 66 Somatuline 66 panitumumab Vectibix 66 Tarceva TM 66 basiliximab 66 gets USFDA nod 66 Novartis Afinitor 66 rosiglitazone maleate 66 bladder ovarian 66 Remicade infliximab 66 Temodar temozolomide 66 Rituxan rituximab 66 chronic idiopathic thrombocytopenic purpura 66 Orphan designation 66 metastatic kidney 66 Herceptin trastuzumab 66 Sorafenib 66 Mycophenolate Mofetil 66 Initiate Clinical Trial 66 Campath alemtuzumab 66 Monopril 66 Begins Dosing 66 metastatic castration resistant 66 phase III isavuconazole 66 Vitrasert R 66 docetaxel Taxotere R 66 mesylate 66 pioglitazone hydrochloride 66 Xeloda capecitabine 65 Onglyza saxagliptin 65 TroVax ® 65 mapatumumab 65 IG HCR ;) CO 65 ASONEP ™ 65 bortezomib Velcade 65 TEMODAL 65 subependymal giant cell 65 thetreatment 65 microtubule inhibitor 65 Imuran 65 Cloretazine 65 beta 1a 65 refractory acute promyelocytic 65 Xelox 65 Febuxostat 65 Fludara ® 65 refractory myeloma 65 Mitoxantrone 65 Pemetrexed 65 Lenalidomide 65 cyclophosphamide chemotherapy 65 Positive Opinion 65 metastatic malignant 65 Brilique 65 Orphan Status 65 HSP# inhibitor 65 Stedesa 65 FUSILEV enhances 65 Gleevec Glivec 65 Vectibix panitumumab 65 mitoxantrone plus 65 Neulasta R 65 Oxaliplatin 65 imatinib Gleevec ® 65 interferon gamma 1b 65 levosimendan 65 Silodosin 65 BRAF inhibitor 65 aripiprazole Abilify 65 Vidaza R 65 developer Antisoma plc 65 severe hypercholesterolemia 65 Navelbine ® 65 fluvastatin Lescol 65 Doxil ® 65 Paliperidone Palmitate 65 Etravirine 65 ALN HPN 65 haematological malignancies 65 Capoten 65 Investigational Treatment 65 itraconazole Sporanox 65 sorafenib tablets 65 Tredaptive 65 Mabthera 65 eflornithine 65 Dacogen decitabine 65 Epirubicin 65 dasatinib Sprycel 65 Orencia abatacept 65 Actimmune ® 65 Zometa zoledronic acid 65 Granted Orphan Drug 65 YONDELIS 65 cinacalcet 65 Submits Response 65 Tasigna nilotinib 65 Novartis AG Gleevec 65 Azathioprine 65 Egrifta 65 Aromasin exemestane 65 non resectable metastatic 65 Immunotherapeutic 65 Wyeth Enbrel 65 5 FU leucovorin 65 Hydrochlorothiazide 65 erlotinib Tarceva 65 ADP receptor antagonist 65 AG NOVN.VX 65 inhalation powder 65 Glaxo Tykerb 65 cyclophosphamide methotrexate 65 Genentech Rituxan 65 Ixabepilone 65 AstraZeneca Symbicort 65 Desvenlafaxine 65 R Saizen R 65 Jevtana 65 Syndrome LEMS 65 Lilly Gemzar 65 Fast Track Status 65 candesartan cilexetil 65 Completes Patient Enrollment 65 tamoxifen citrate 64 alkylating agent 64 Mestinon 64 immunomodulatory agents 64 Adentri 64 pill Galvus 64 Serostim ® 64 Trovax 64 Sunitinib 64 Cellcept 64 Fingolimod 64 advanced metastatic renal 64 exocrine pancreatic insufficiency EPI 64 OMAPRO ™ 64 nucleotide analogue 64 Everolimus 64 alfa 2a 64 Temodal 64 Neupogen ® 64 Aceon 64 Camptosar 64 RANK Ligand inhibitor 64 Teysuno 64 acetonide FA 64 Sandimmune 64 tumors GIST 64 reslizumab 64 anthracyclines taxanes 64 Vincristine 64 trabectedin 64 DEB# 64 LymphoStat B TM 64 RezularTM 64 relapsed ovarian cancer 64 combines bupropion 64 Tacrolimus 64 Aliskiren 64 blood clot dissolving 64 Onyx Pharmaceuticals Inc 64 Mg Uk 64 Intravitreal 64 Lilly Alimta 64 ZOLINZA 64 AstraZeneca Plc Crestor 64 Certolizumab pegol 64 Tesmilifene 64 Neulasta ® 64 vapreotide acetate 64 Raptiva R 64 trastuzumab DM1 64 pravastatin Pravachol 64 psoriasis rheumatoid arthritis 64 #/#mg 64 NOVARTIS 64 Roche Avastin 64 Afinitor everolimus 64 Celebrex celecoxib 64 Dabigatran 64 Eraxis 64 enoxaparin Lovenox 64 insulin glulisine 64 AstraZeneca Arimidex 64 Zavesca 64 ixabepilone 64 Initiates Phase II 64 Novartis Glivec 64 ELIQUIS 64 Kuvan sapropterin dihydrochloride 64 Adjuvant Treatment 64 p# MAP kinase inhibitor 64 Modrenal R 64 sitagliptin metformin 64 THALOMID R 64 peginterferon alpha 2a 64 Friedreich Ataxia FRDA 64 cinacalcet HCl 64 TOPAMAX R 64 hypereosinophilic syndrome 64 palifermin 64 nilotinib Tasigna 64 Eliquis 64 histone deacetylase inhibitor 64 HERCEPTIN 64 Pertuzumab 64 Riluzole 64 hoFH 64 Losartan 64 Eribulin 64 cetuximab Erbitux ® 64 Advagraf 64 Roche Actemra 64 Mg Usa 64 Files IND 64 Mimpara 64 MKC# MT 64 INSPIRE Trial Phase III 64 Kit CD# positive 64 Expanded Indication 64 SIR Spheres 64 Anidulafungin 64 lapatinib Tykerb 64 Announces Tentative Approval 64 miconazole Lauriad 64 multi kinase inhibitor 64 standard chemotherapy regimen 64 cisplatin gemcitabine 64 commercialize deforolimus 64 antifibrinolytic 64 olaparib 64 pancreatic enzyme replacement 64 Achieves Primary Endpoint 64 Hodgkin lymphoma HL 64 Receives Positive Opinion 64 gastrointestinal stromal tumor GIST 64 Kiacta 64 Hervé Hoppenot President 64 dual endothelin receptor antagonist 64 pafuramidine maleate 64 sunitinib malate 64 #mg Tablets [002] 64 unresectable liver cancer 64 ß blockers 64 metastatic renal cell carcinoma 64 investigational monoclonal antibody 64 Geodon ziprasidone 64 sedative pentobarbital sodium 64 Sustiva efavirenz 64 Recombinant interferon alpha 64 Eltrombopag 64 Mimpara R 64 LHRH receptor positive 64 PrevOnco 64 Crestor rosuvastatin 64 histone deacetylase HDAC inhibitor 64 Eloxatin oxaliplatin 64 Ceflatonin 64 FDA Accepts 64 Supplemental Biologics License Application 64 Neoadjuvant 64 Bosutinib 64 Sebivo 64 sorafenib tosylate 64 Actos pioglitazone 64 acyclovir Lauriad R 64 Xeloda ® 64 Revolade 64 aerosolized AAT 64 Cipro ciprofloxacin 64 phase IIb trial 63 Onconase 63 Boniva ibandronate 63 mertansine 63 Aptivus ® 63 pegylated liposomal doxorubicin 63 polycythemia vera essential thrombocythemia 63 Zybrestat 63 AGGRASTAT R Injection tirofiban 63 Cell Lymphoma CTCL 63 Kaletra lopinavir ritonavir 63 everolimus Afinitor 63 Amgen Vectibix 63 Novartis Femara 63 superficial basal cell carcinoma 63 pemetrexed Alimta 63 prokinetic agent 63 Aricept Exelon 63 Clofarabine 63 bevacizumab Avastin R 63 G#DT 63 leukemia multiple myeloma 63 Canvaxin 63 Prilosec omeprazole 63 gastrointestinal stromal tumors 63 demonstrated antitumor activity 63 Myfortic 63 Fortovase 63 Novartis Gleevec 63 virus HCV protease inhibitor 63 Alkeran 63 relapsing remitting MS RRMS 63 gemcitabine Gemzar 63 anti inflammatory NSAID 63 Emtriva emtricitabine 63 investigational oral hepatitis C 63 Pamidronate 63 mTOR mammalian target 63 gastrointestinal stromal tumors GIST 63 chronic thromboembolic pulmonary 63 trastuzumab Herceptin 63 Onrigin 63 Gefitinib 63 ZACTIMA 63 Selective Internal 63 Anastrozole 63 Trandolapril 63 Nitazoxanide 63 antibody MAb 63 BYETTA exenatide injection 63 buccal tablets 63 Investigational Compound 63 Humira adalimumab 63 FDA APPROVES 63 Prednisone Against Refractory 63 antihormonal 63 Tigecycline 63 methylnaltrexone bromide 63 recurrent metastatic 63 GTC recombinant human 63 Amgen Nplate 63 Simponi golimumab 63 PPAR gamma agonist 63 Paraplatin ® 63 cediranib 63 Submits NDA 63 Panzem NCD 63 losartan Cozaar 63 Pegloticase 63 cell carcinoma RCC 63 bone marrow reticulin deposition 63 Tamsulosin 63 Bristol Myers Squibb Pravachol 63 Certican 63 ACOMPLIA R 63 antibody MT# 63 Preotact R 63 Bazedoxifene 63 Didanosine 63 Copegus ribavirin 63 adriamycin 63 ergot derivatives 63 pan HDAC inhibitor 63 advanced medullary thyroid 63 SPRYCEL ® 63 selective estrogen receptor modulator 63 targeted antifolate 63 Launches Generic Version 63 stage IIIb IV 63 rotigotine transdermal patch 63 PRN FDA Approves 63 glucocorticoid induced osteoporosis 63 Biogen Idec Avonex 63 thromboembolisms 63 multiple myeloma MM 63 Anticancer Drug 63 Navelbine R 63 TELINTRA 63 Gonal f 63 PEGylated Fab fragment 63 metformin XR 63 Oporia 63 Receives Approvable Letter 63 tenofovir Viread 63 TO AVOID PREGNANCY WHILE 63 proteasome inhibitor 63 tazobactam 63 Arixtra 63 sapropterin dihydrochloride 63 Bevacizumab 63 PEGINTRON TM 63 Taxotere ® 63 Fablyn 63 Evoltra TM 63 chronic eosinophilic leukemia 63 pamidronate 63 RhuDex R 63 immune globulin intravenous 63 Pfizer Camptosar 63 antibiotic Tygacil 63 Aplidin 63 FOLFOX6 63 Nexavar ® 63 SYCREST 63 Injectafer 63 Capecitabine 63 efalizumab 63 Heterozygous Familial Hypercholesterolemia 63 zoledronic acid Zometa 63 Prolongs Survival 63 vinca alkaloid 63 Crizotinib 63 Antitumor Activity 63 RhuDex 63 parecoxib 63 Hematological Malignancies 63 temsirolimus 63 orphan designation 63 alefacept 63 Glivec imatinib 63 idiopathic thrombocytopenic purpura ITP 63 Orphan Drug Status 63 Interferon beta 1b 63 thiazolides 63 Zorbtive TM 63 Application MAA 63 OncoVex 63 novel emulsion formulation 63 Glatiramer Acetate 63 Mylan Receives Approval 63 Refractory Hodgkin Lymphoma 63 dalteparin 63 TLK# 63 OvaRex ® MAb 63 metastatic hormone refractory 63 ONGLYZA ™ 63 cardiovascular calcification 63 metastatic gastric 63 Surgical resection 63 liposomal doxorubicin 63 Tyverb 63 lenalidomide Revlimid R 63 refractory acute myeloid 63 rituximab Rituxan 63 Eprodisate 63 PTK# 63 Plavix clopidogrel bisulfate 63 Dose Ranging Study 63 Allovectin 7 63 Esbriet ® 63 Kepivance 63 Actonel risedronate 63 Safinamide 63 biliary tract cancer 63 Trobalt 63 amifostine 63 lintuzumab SGN 63 non nucleoside inhibitor 63 Xinlay 63 Troxatyl TM 62 Amrubicin 62 Potiga 62 indinavir Crixivan 62 Novartis Zometa 62 Exforge HCT 62 Mipomersen 62 Dasatinib 62 #mg ATC 62 Telzir 62 Ridaforolimus 62 IAP inhibitor 62 FDA Approvals 62 Orally administered 62 Amgen Neulasta ® 62 lamotrigine Lamictal 62 Myoblast 62 AstraZeneca PLC AZN AZN.LN 62 Paraplatin 62 HCl capsules 62 Drug Fails 62 Bucindolol 62 rosuvastatin Crestor 62 Generic Version 62 Personalized Immunotherapy 62 Submits Biologics License Application 62 Hexvix ® 62 Drug Candidate 62 nucleoside analog 62 Videx Videx EC 62 IAP inhibitors 62 rasagiline tablets 62 Dynepo TM 62 RhuDex TM 62 Zolinza 62 Zidovudine Tablets 62 essential thrombocythemia ET 62 Sporanox 62 dihydrochloride 62 CIMZIA ® 62 OMP #R# 62 Roche Pegasys 62 Receive Milestone Payment 62 Gilead Viread 62 terlipressin 62 fluoropyrimidine 62 epoetin zeta 62 Novartis AG NOVN.VX 62 Starlix 62 Lapatinib 62 Renal Cancer 62 Kuvan R 62 volociximab 62 Pyridorin 62 antiplatelets 62 antibody trastuzumab 62 5 Fluorouracil 62 ASONEP TM 62 Pivotal Phase III 62 vinflunine 62 Triapine 62 Caelyx 62 FOLOTYN ® 62 Phase 2b Clinical Trial 62 MyVax R 62 relapsed MM 62 ezetimibe Zetia 62 herpetic keratitis 62 PKC# 62 aspirin clopidogrel 62 oral ridaforolimus 62 chemoradiation therapy 62 ARIXTRA R 62 ISENTRESS raltegravir 62 MGd 62 Factor Xa inhibitor 62 Novartis AG Foradil 62 Cytarabine 62 taxane chemotherapy 62 TheraCIM h R3 62 Zenpep 62 substantially excreted 62 gemcitabine chemotherapy 62 refractory APL 62 Complicated Skin 62 Dr. McHutchison 62 Thalidomide Pharmion 62 Hycamtin ® 62 zoledronic acid Reclast 62 mTOR inhibitor 62 Alnylam Nasdaq ALNY 62 diarrhea predominant irritable 62 Node Positive 62 adenosine injection 62 refractory CLL 62 patientswith 62 Valtropin 62 aromatase inhibitors AIs 62 Pramlintide 62 metastatic colorectal carcinoma 62 TNF blocker 62 Li Fraumeni Syndrome 62 Peginterferon 62 Teriparatide 62 Alemtuzumab 62 UCB Cimzia 62 Tarceva erlotinib 62 targeted nucleotide prodrug 62 Marketing Authorisation Application MAA 62 Vitaxin 62 Adjuvant chemotherapy 62 RoActemra 62 Temozolomide 62 Raptiva efalizumab 62 Monoclonal antibody 62 Daclizumab 62 Irinotecan Hydrochloride Injection 62 rivastigmine Exelon 62 R bendamustine hydrochloride 62 rabeprazole 62 COLAZAL R 62 pentostatin 62 treating neuropathic pain 62 whose tumors overexpress 62 Submits IND 62 Maribavir 62 progressive metastatic prostate 62 Treanda bendamustine 62 metastatic castrate resistant 62 Novartis Diovan 62 Ezetrol 62 Novel Oral 62 ThermoDox R 62 Alvesco ® 62 Lopressor 62 Relapsed Refractory 62 EVIZON TM 62 IMiDs ® 62 Initiate Phase 62 selective phosphodiesterase 62 Cabazitaxel 62 nonsteroidal 62 abacavir Ziagen 62 Omnitarg 62 denileukin diftitox 62 Cyclosporin 62 anti CD3 antibody 62 Epivir 62 Vernakalant 62 Neuvenge 62 infliximab Remicade 62 Novartis AG NVS NOVN.VX 62 ® darbepoetin alfa 62 Aurograb 62 Cloretazine ® 62 chemosensitizer 62 refractory colorectal cancer 62 Civacir 62 Receives Fast Track 62 mRCC 62 Known generically 62 Fludarabine 62 Ellence 62 Cetuximab Erbitux 62 Epratuzumab 62 Flomax tamsulosin 62 BCR ABL inhibitor 62 acadesine 62 Vpriv 62 Ambrisentan 62 Cholestagel 62 Tipranavir 62 Fosphenytoin 62 MetroGel 62 small molecule tyrosine 62 Cutaneous T 62 Squalamine 62 valacyclovir Valtrex 62 Investigational Oral 62 Tocilizumab 62 neoadjuvant setting 62 alfa 2b 62 Sodium Injection 62 TNKase 62 Zemplar 62 nitrofurantoin 62 nasal calcitonin product 62 BRILINTA 62 Mycamine 62 CONBRIZA 62 receptor modulators 62 eritoran 62 lymphoid malignancies 62 NYSE PFE Exelon Rivastigmine 62 infusional 5-FU/LV 62 injectable antibiotic 62 Rivastigmine 62 Marketing Authorisation Application 62 tyrosine kinase inhibitors TKIs 62 Entecavir 62 rufinamide 62 PNP inhibitor 62 MERREM 62 HMG CoA reductase inhibitors 62 Naive Patients 62 Initiates Clinical 62 GlaxoSmithKline plc GSK 62 Vertex telaprevir 62 chemotherapeutic regimen 62 RSR# 62 intranasal formulation 62 ticagrelor Brilinta 62 HoFH 62 Lipitor atorvastatin calcium 62 induced macular edema 62 Tyrosine Kinase Inhibitor 62 ABX EGF 62 Piperacillin 62 Neurontin gabapentin 62 Astex Therapeutics 62 chemotherapy cisplatin 62 Danazol 62 Presents Positive 62 vinorelbine tartrate 62 STELARA TM 62 CLL SLL 62 paclitaxel Taxol 62 Wellstat 62 Hedgehog Pathway Inhibitor 62 Trisenox 62 RNA antagonists 62 non splenectomized 62 paclitaxel Taxol ® 62 investigational humanized monoclonal antibody 62 oral clodronate 61 KRN# 61 orally disintegrating 61 Evoltra ® 61 Pegylated Interferon 61 adjuvant cisplatin 61 Diabetic Neuropathy 61 Zavesca R 61 Shows Efficacy 61 treat enlarged prostate 61 adefovir dipivoxil 61 orphan medicinal product 61 chemotherapy FOLFOX 61 Clolar ® 61 k Premarket Notification 61 Eli Lilly Alimta 61 FOR FURTHER INFORMATION ABOUT 61 danazol 61 oncological indications 61 Evista raloxifene 61 Boceprevir 61 generation purine nucleoside 61 darbepoetin alfa Aranesp 61 pegylated interferon alpha 61 Atrasentan 61 relapsed leukemia 61 Gliadel Wafer 61 Zytiga 61 Novartis Reclast 61 galiximab 61 Pafuramidine 61 Lipitor atorvastatin 61 Pirfenidone 61 Final Appraisal Determination 61 Progressive Multifocal Leukoencephalopathy 61 rimonabant Acomplia 61 Vion Pharmaceuticals 61 Annamycin 61 REVLIMID R 61 Microwave Ablation System 61 briakinumab 61 kidney urologic 61 Entocort 61 advanced HER2 positive 61 AstraZeneca AZN.L 行情 61 Manja Bouman CEO 61 Adenuric R 61 Bosentan 61 Previously Treated 61 Epivir HBV 61 posaconazole 61 antibiotic ceftobiprole 61 Vorapaxar 61 gabapentin Neurontin 61 benign prostatic hypertrophy BPH 61 anthracycline containing 61 haematologic malignancies 61 Vitrasert ® 61 Soriatane 61 Xyfid TM 61 Proquin XR 61 valganciclovir 61 Dabigatran etexilate 61 balsalazide disodium Capsules 61 Novantrone 61 opioid induced constipation OIC 61 Fosamax alendronate 61 intra arterial chemotherapy 61 metastatic pancreatic 61 raloxifene Evista 61 cytomegalovirus immune globulin 61 Proellex TM 61 Sudhir Agrawal D.Phil 61 Lilly Cymbalta 61 Reports Preclinical Data 61 Epidermal Growth Factor Receptor 61 mycophenolate mofetil 61 evaluating T DM1 61 oral salmon calcitonin 61 EGFR expressing mCRC 61 anti angiogenic agents 61 Boxed Warnings 61 Grants Orphan Drug 61 abacavir lamivudine 61 relapsed ALL 61 R abatacept 61 Lipid lowering 61 homozygous familial hypercholesterolemia 61 allogeneic hematopoietic stem cell 61 Kynapid 61 Frovatriptan 61 Ethyol 61 HIV treatments Reyataz 61 ATACAND 61 pertuzumab 61 Degarelix 61 Ranolazine 61 Therapeutic Competitors Companies 61 Symbicort asthma 61 Edurant 61 MabThera rituximab 61 unresectable tumors 61 Receives Orphan Drug 61 GlaxoSmithKline Plc Novartis AG 61 treat chronic sinusitis 61 efaproxiral 61 DepoCyt 61 invasive candidiasis 61 Glatiramer acetate 61 leukemia AML 61 induced anemia 61 Trastuzumab DM1 61 Pegasys peginterferon alfa 2a 61 baminercept 61 Keppra ® levetiracetam 61 untreated metastatic colorectal 61 vandetanib 61 Cimzia certolizumab pegol 61 carbamazepine phenobarbital phenytoin rifampin 61 MOVIPREP R 61 Gonal f R 61 Omalizumab 61 Olmesartan 61 Carvedilol 61 Generic Versions 61 omacetaxine mepesuccinate 61 Presents Preclinical Data 61 Enbrel etanercept 61 ImClone Erbitux 61 Orphan Drug status 61 aflibercept VEGF Trap 61 blood thinner Xarelto 61 paclitaxel cisplatin 61 sitaxsentan sodium 61 Carbamazepine 61 Avastin bevacizumab Genentech 61 Retacrit 61 PROCRIT R 61 SIMCOR 61 glatiramer 61 LymphoStat B belimumab 61 PegIntron 61 5 FU capecitabine 61 Phase #b/#a clinical 61 clobazam 61 oral prodrug 61 Yondelis ® 61 hormone LHRH antagonist 61 Diamyd r 61 Orphan Medicinal Product 61 CAELYX 61 ELACYT 61 rheumatoid arthritis sufferers 61 aurora kinase 61 immunosuppressant drug 61 Gemzar ® 61 Firazyr 61 DPP4 inhibitor 61 Adjunctive 61 neratinib 61 Truvada Viread 61 Glioblastoma Multiforme 61 cytokine refractory 61 ORENCIA R 61 vismodegib 61 Ziprasidone 61 Activase 61 Calcitonin 61 temozolomide Temodar 61 Recombinant Human 61 Halaven 61 Lung Cancer Drug